Paired specimens for pre- and post-NET tumor HER1–4 assessments were available for 35 tumors and we identified upregulation of HER2 protein in 17 tumors (48.5%), including two that converted to HER2 IHC3 + status at surgery. Here, ERBB2 is linked to neoplasm.